Regenicin, Inc.

Symbol: RGIN




Market price today

  • -0.0807

    P/E Ratio

  • 0.0019

    PEG Ratio

  • 0.08M

    MRK Cap

  • 0.00%

    DIV Yield

Regenicin, Inc. (RGIN) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Randall E. McCoy
Full-time employees:3
City:Little Falls
Address:10 High Court

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

General Outlook

In simple terms, Regenicin, Inc. has 153.483 M shares that people are buying and selling right now.

Return on Investments

The company's asset efficiency, represented by a robust -0.080% return, is a testament to Regenicin, Inc.'s adeptness in optimizing resource deployment. Regenicin, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.164%. Furthermore, the proficiency of Regenicin, Inc. in capital utilization is underscored by a remarkable 0.150% return on capital employed.

Stock Prices

Regenicin, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.0021, while its low point bottomed out at $0.0021. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Regenicin, Inc.'s stock market.

Frequently Asked Question

How many company shares are outstanding in 2023?

There are stock number shares outstanding of Regenicin, Inc. (RGIN) on the PNK in 2023.

What is P/E ratio of enterprise in 2023?

The current P/E ratio of enterprise is -0.081 in 2023.

What is the ticker symbol of Regenicin, Inc. stock?

The ticker symbol of Regenicin, Inc. stock is RGIN.

What is company IPO date?

IPO date of Regenicin, Inc. is 2009-11-16.

What is company current share price?

Current share price is 0.001 USD.

What is stock market cap today?

The market cap of stock today is 76742.000.

What is PEG ratio in 2023?

The current 0.002 is 0.002 in 2023.

What is the number of employees in 2023?

In 2023 the company has 3.